The Patent Finder

Janssen Pharmaceutica N.V.

Also on record
Records under this name other than the patents Janssen Pharmaceutica N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 458 patents it holds.

Back to Janssen Pharmaceutica N.V.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,133,895Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
now held by Galapagos, N.V.
In force
 · High confidence
In forceHigh confidence
US 8,609,865Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid
In force
 · High confidence
In forceHigh confidence
US 8,691,860Novel crystals and process of making 5-({(2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC ACID
conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company
In force
 · High confidence
In forceHigh confidence
US 8,859,604Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company
In force
 · High confidence
In forceHigh confidence
US 9,115,091Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company
In force
 · High confidence
In forceHigh confidence
US 9,364,489Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid
conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company
In force
 · High confidence
In forceHigh confidence
US 9,789,125Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6-Dimethyl-PHENYL)-PROPIONYL]-[1-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid
conveyed to Furiex Pharmaceuticals Inc. - now held by Allergan Holdings Unlimited Company
In force
 · High confidence
In forceHigh confidence
US 7,799,824Quaternary Salt CCR2 Antagonists
now held by Kenvue Brands LLC
In force
 · High confidence
In forceHigh confidence
US 7,994,206Novel Crystals and Process of Making 5-({[2-Amino-3-(4-Carbamoyl-2,6- DIMETHYL-PHENYL)-PROPIONYL]-(4-Phenyl-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-Methoxy-BENZOIC Acid
In force
 · High confidence
In forceHigh confidence
US 8,426,434Crystalline Form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]-AMINO]-2-Pyrimidinyl]AMINO]BENZONITRILE
conveyed to Tibotec Pharmaceuticals Ltd. - now held by Janssen Sciences Ireland Unlimited Company
In force
 · High confidence
In forceHigh confidence
10 of 1,330 records shown.
Pro members see all 1,330.
Pro members: see all 1,330 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited